<DOC>
	<DOCNO>NCT02805985</DOCNO>
	<brief_summary>This study post-market clinical follow-up study . A post-market , prospective clinical trial conduct . The data collect study serve purpose confirm safety performance FLXfit™ implant .</brief_summary>
	<brief_title>Post-market Surveillance Study FLXfit™ TLIF Interbody Fusion Device</brief_title>
	<detailed_description>As detailed Expanding Orthopedics Inc. , FLXfit™ expandable , articulate interbody fusion device ( IBFD ) use conjunction supplemental fixation provide structural stability skeletally mature individual follow total partial discectomy . The FLXfit™ unique titanium cage articulate laterally well expand height . This enable large footprint support well restoration disc height lordotic angle correction . A bullet-nose design facilitate self-distraction ease insertion . The open architecture device allow pack autogenous bone graft .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Adult ( 1870 y/o ) Male Female With follow condition lumbar spine confirm advanced imaging ( CT MRI ) , candidate primary spinal fusion procedure accord acceptable criterion medical condition : Degenerative disc disease Grade I spondylolisthesis Spondylolisthesis Failure least 6months conservative treatment BMI &lt; 40 Patient approve pregnancy 24 month study participation study parallel one Ability read , understand , sign inform consent Infection , local operative site Signs local inflammation Fever leukocytosis Pregnancy Significant mental disorder condition could compromise patient 's ability remember comply preoperative postoperative instruction ( e.g . current treatment psychiatric/psychosocial disorder , senile dementia , Alzheimer 's disease , traumatic head injury ) Prior surgical procedure ( exception decompression procedure ) index level ( ) use desire operative approach Prior fusion procedure adjacent level Any condition would preclude potential benefit spinal implant surgery , presence tumor congenital abnormality , fracture local operating site , elevation segmentation rate unexplained disease , elevation white blood count ( WBC ) , mark left shift WBC differential count Neuromuscular disorder would engender unacceptable risk instability , implant fixation failure , complication postoperative care Active local infection near operative region Active systemic infection and/or disease Severe osteoporosis insufficient bone density , medical opinion physician preclude surgery contraindicates instrumentation Endocrine metabolic disorder know affect osteogenesis ( e.g . Paget 's disease , renal osteodystrophy , hypothyroidism ) Systemic disease require chronic administration nonsteroidal antiinflammatory steroidal drug Suspected document allergy intolerance implant 's material Symptomatic cardiac disease Patient unwilling cooperate postoperative instruction . Any case implant component select use would large small achieve successful result . Patient inadequate tissue coverage operative site inadequate bone stock quality . Any patient implant utilization would interfere anatomical structure expect physiological performance . Prior fusion level treat . Back VAS &lt; 4/10</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Degenerative Disc Disease</keyword>
	<keyword>Spondylolisthesis</keyword>
	<keyword>Retrolisthesis</keyword>
</DOC>